{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:22:29Z","timestamp":1761675749475},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ygyno.2010.03.014","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T08:07:37Z","timestamp":1274083657000},"page":"202-207","source":"Crossref","is-referenced-by-count":36,"title":["Hormone prevention strategies for breast, endometrial and ovarian cancers"],"prefix":"10.1016","volume":"118","author":[{"given":"Laurel W.","family":"Rice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.03.014_bib1","unstructured":"National Cancer Institute. U.S. National Institutes of Health. http:\/\/seer.cancer.gov\/."},{"key":"10.1016\/j.ygyno.2010.03.014_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","volume":"148","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.03.014_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/ajc.1936.217","volume":"27","author":"Lacassagne","year":"2000","journal-title":"Am. J. Cancer"},{"key":"10.1016\/j.ygyno.2010.03.014_bib4","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individual probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J. Natl. Cancer. Inst."},{"key":"10.1016\/j.ygyno.2010.03.014_bib5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifin for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J. Natl. Cancer. Inst."},{"issue":"9354","key":"10.1016\/j.ygyno.2010.03.014_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"issue":"9122","key":"10.1016\/j.ygyno.2010.03.014_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"issue":"9122","key":"10.1016\/j.ygyno.2010.03.014_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)85011-3","article-title":"Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomized women. Italian Tamoxifin Prevention Study","volume":"352","author":"Veronesi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2010.03.014_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2001.tb04010.x","article-title":"A brief review of the International Breast Cancer Intervention Study (IBIS), the other current breast cancer prevention trials, and proposals for future trials","volume":"949","author":"Cuzick","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ygyno.2010.03.014_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1749-6632.2001.tb04043.x","article-title":"Tamoxifen for the reduction in the incidence of breast cancer in women at high risk for breast cancer","volume":"949","author":"Honig","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"23","key":"10.1016\/j.ygyno.2010.03.014_bib11","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2010.03.014_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","article-title":"Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention","volume":"95","author":"Freedman","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"21","key":"10.1016\/j.ygyno.2010.03.014_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer","volume":"91","author":"Gail","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.ygyno.2010.03.014_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.20205","article-title":"Acceptance of tamoxifen chemoprevention by physicians and women at risk","volume":"100","author":"Tchou","year":"2004","journal-title":"Cancer"},{"issue":"30","key":"10.1016\/j.ygyno.2010.03.014_bib15","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2010.03.014_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2006.01.006","article-title":"Histopathology of BRCA1- and BRCA2-associated breast cancer","volume":"59","author":"Honrado","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"18","key":"10.1016\/j.ygyno.2010.03.014_bib17","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"issue":"9324","key":"10.1016\/j.ygyno.2010.03.014_bib18","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.ygyno.2010.03.014_bib19","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2010.03.014_bib20","series-title":"World Health Organization: tumours of the breast and female genital organs (WHO\/IARC classification of tumours)","author":"Tavassoli","year":"2003"},{"issue":"9","key":"10.1016\/j.ygyno.2010.03.014_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.ygyno.2010.03.014_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00002018-200124100-00003","article-title":"Oral contraceptives and cancer: an update","volume":"24","author":"La Vecchia","year":"2001","journal-title":"Drug Saf."},{"issue":"7621","key":"10.1016\/j.ygyno.2010.03.014_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1016\/j.ygyno.2010.03.014_bib24","first-page":"S94","article-title":"Weight control and physical activity in cancer prevention: international evaluation of the evidence","volume":"11","author":"Vainio","year":"2002","journal-title":"Eur. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2010.03.014_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00115635","article-title":"Nutrition and endometrial cancer","volume":"7","author":"Hill","year":"1996","journal-title":"Cancer Causes Control"},{"issue":"17","key":"10.1016\/j.ygyno.2010.03.014_bib26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2010.03.014_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cdp.2003.09.002","article-title":"Trends in incidence rates for obesity-associated cancers in the US","volume":"27","author":"Polednak","year":"2003","journal-title":"Cancer Detect. Prev."},{"issue":"21","key":"10.1016\/j.ygyno.2010.03.014_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/djh291","article-title":"Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study","volume":"96","author":"Schouten","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2010.03.014_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ije\/dyi226","article-title":"Weight change and risk of endometrial cancer","volume":"35","author":"Trentham-Dietz","year":"2006","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ygyno.2010.03.014_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejogrb.2005.09.004","article-title":"The management of endometrial hyperplasia: an evaluation of current practice","volume":"125","author":"Clark","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.ygyno.2010.03.014_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006254-200405000-00025","article-title":"Endometrial hyperplasia: a review","volume":"59","author":"Montgomery","year":"2004","journal-title":"Obstet. Gynecol. Surv."},{"issue":"3","key":"10.1016\/j.ygyno.2010.03.014_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/beog.2000.0184","article-title":". Optimal management of endometrial hyperplasia","volume":"15","author":"Marsden","year":"2001","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.ygyno.2010.03.014_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia\u2014a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2010.03.014_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/AOG.0b013e31817d53a4","article-title":"Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women","volume":"112","author":"Kwon","year":"2008","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2010.03.014_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jmg.2004.024299","article-title":"Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment","volume":"42","author":"Quehenberger","year":"2005","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.ygyno.2010.03.014_bib36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/jama.296.12.1507","article-title":"Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review","volume":"296","author":"Lindor","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2010.03.014_bib37","series-title":"Cancer facts and figures 2009","year":"2009"},{"issue":"3","key":"10.1016\/j.ygyno.2010.03.014_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/oxfordjournals.aje.a114993","article-title":"Measuring the separate effects of low parity and its antecedents on the incidence of ovarian cancer","volume":"128","author":"Weiss","year":"1988","journal-title":"Am. J. Epidemiol."},{"issue":"8932","key":"10.1016\/j.ygyno.2010.03.014_bib39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","article-title":"Parity, age at first childbirth, and risk of ovarian cancer","volume":"344","author":"Adami","year":"1994","journal-title":"Lancet"},{"issue":"3 Pt 2","key":"10.1016\/j.ygyno.2010.03.014_bib40","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1006\/gyno.1994.1334","article-title":"Characteristics relating to ovarian cancer risk: implications for prevention and detection","volume":"55","author":"Whittemore","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2010.03.014_bib41","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2010.03.014_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","article-title":"Clinical practice. Screening for ovarian cancer","volume":"361","author":"Clarke-Pearson","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ygyno.2010.03.014_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","volume":"316","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"9609","key":"10.1016\/j.ygyno.2010.03.014_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2010.03.014_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2010.03.014_bib46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810002647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810002647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:50:37Z","timestamp":1559112637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810002647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090825810002647"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.03.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}